Zimmer Biomet Holdings, Inc. (ZBH) Financials

NYSE:ZBH

Market Cap

25.39B

Total Revenue

6.94B

Gross Profit

4.92B

Operating Income

1.06B

Net Income

231.40M

Metric	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
revenue	4,623,400,000	4,673,300,000	5,997,800,000	7,683,900,000	7,824,100,000	7,932,900,000	7,982,200,000	7,024,500,000	6,827,300,000	6,939,900,000
costOfRevenue	1,286,100,000	1,249,800,000	1,856,600,000	2,374,900,000	2,132,900,000	2,271,900,000	2,252,600,000	2,128,300,000	1,960,400,000	2,019,500,000
grossProfit	3,337,300,000	3,423,500,000	4,141,200,000	5,309,000,000	5,691,200,000	5,661,000,000	5,729,600,000	4,896,200,000	4,866,900,000	4,920,400,000
researchAndDevelopmentExpenses	204,200,000	188,300,000	268,800,000	365,600,000	367,400,000	391,700,000	449,300,000	372,000,000	435,800,000	406,000,000
sellingAndMarketingExpenses	--	--	--	--	--	--	--	--	--	--
generalAndAdministrativeExpenses	1,833,800,000	1,822,500,000	2,284,200,000	2,932,900,000	2,973,900,000	3,379,300,000	--	3,177,800,000	--	--
sellingGeneralAndAdministrativeExpenses	1,833,800,000	1,822,500,000	2,284,200,000	2,932,900,000	2,973,900,000	3,379,300,000	3,343,800,000	3,177,800,000	2,843,400,000	2,761,700,000
operatingExpenses	2,038,000,000	2,010,800,000	2,901,600,000	3,864,400,000	3,945,200,000	4,513,800,000	4,459,800,000	4,198,300,000	3,861,500,000	3,728,300,000
operatingIncome	1,035,600,000	1,034,700,000	326,400,000	827,900,000	823,200,000	33,800,000	1,137,500,000	723,300,000	860,300,000	1,064,100,000
totalOtherIncomeExpensesNet	-263,700,000	-417,600,000	-950,100,000	-688,000,000	-941,100,000	-1,129,000,000	-231,700,000	-997,700,000	-361,300,000	-660,600,000
ebitda	1,673,400,000	1,385,000,000	1,935,600,000	2,415,500,000	2,792,600,000	2,175,400,000	2,271,100,000	1,756,000,000	1,955,300,000	1,990,500,000
depreciationAndAmortization	358,500,000	375,800,000	723,500,000	1,039,300,000	1,062,700,000	1,040,500,000	1,133,600,000	1,032,700,000	1,095,000,000	926,400,000
interestIncome	15,600,000	11,900,000	9,400,000	2,900,000	2,200,000	3,300,000	--	--	--	--
interestExpense	70,100,000	63,100,000	286,600,000	357,900,000	327,500,000	292,600,000	226,900,000	212,000,000	208,400,000	164,800,000
incomeBeforeTax	981,100,000	943,900,000	12,300,000	401,600,000	479,600,000	-271,100,000	905,800,000	-274,400,000	499,000,000	403,500,000
incomeTaxExpense	221,900,000	224,900,000	-36,600,000	100,000,000	-1,359,600,000	108,200,000	-225,700,000	-137,000,000	53,500,000	112,300,000
netIncome	761,000,000	720,100,000	49,700,000	302,900,000	1,839,600,000	-379,200,000	1,131,600,000	-137,400,000	401,600,000	231,400,000
eps	4.49	4.26	0.27	1.51	9.11	-1.86	5.52	-0.66	1.93	1.39
epsdiluted	4.43	4.19	0.26	1.5	9.03	-1.86	5.47	-0.66	1.91	1.38
weightedAverageShsOut	169,600,000	169,000,000	187,400,000	200,000,000	201,900,000	203,500,000	205,100,000	207,000,000	208,600,000	209,600,000
weightedAverageShsOutDil	171,800,000	171,700,000	189,800,000	202,400,000	203,700,000	203,500,000	206,700,000	207,000,000	210,400,000	210,300,000
costAndExpenses	3,324,100,000	3,260,600,000	4,758,200,000	6,239,300,000	6,078,100,000	6,785,700,000	6,712,400,000	6,326,600,000	5,821,900,000	5,747,800,000
otherExpenses	6,000,000	-39,600,000	-36,900,000	-71,300,000	-18,300,000	-15,600,000	666,700,000	648,500,000	582,300,000	560,600,000

Key Facts

Industry

Medical Devices

Sector

Healthcare

Headquarters

Warsaw, IN, US

Website

zimmerbiomet.com

CEO

Mr. Bryan C. Hanson

Employees

18000

About the Company

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.